Detection of Chlamydia psittaci in both blood and bronchoalveolar lavage fluid using metagenomic next-generation

Yingpu Yuan1, Xiaobo Zhang2, Chunmei Gui1

  • 1Department of Critical Care Medicine.

Medicine
|July 7, 2021
PubMed
Abstract

Insights

Metagenomic next-generation sequencing (mNGS) successfully detected Chlamydia psittaci in a farmer with severe pneumonia and sepsis. This advanced diagnostic tool is crucial when traditional methods fail to identify specific pathogens.

Area of Science:

  • Infectious Diseases
  • Microbiology
  • Genomics

Background:

  • Chlamydia psittaci (C psittaci), an avian-associated bacterium, causes psittacosis, primarily manifesting as pneumonia in humans.
  • Human infection typically occurs via inhalation of contaminated aerosols, potentially leading to severe illness including sepsis and organ failure.

Observation:

  • A 71-year-old male farmer presented with fever, myalgia, weakness, and cough, indicative of a severe respiratory infection.
  • The patient developed sepsis, severe pneumonia, and multiple organ failure, necessitating intensive treatment.

Findings:

  • Simultaneous detection of C psittaci in both blood and bronchoalveolar lavage fluid was achieved using metagenomic next-generation sequencing (mNGS).
  • Treatment with doxycycline and meropenem led to clinical improvement, with resolution of fever and radiographic lesions.

Implications:

  • mNGS offers a powerful diagnostic approach for identifying challenging pathogens like C psittaci, especially when conventional tests are inconclusive.
  • This case highlights the utility of mNGS in diagnosing severe infections and guiding appropriate anti-infective therapy.